Rishiratna Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -89.07%
(FY 2022)
- Profit -105.43%
(FY 2022)
- Ebitda -140.13%
(FY 2022)
- Net Worth -15.86%
(FY 2022)
- Total Assets -11.30%
(FY 2022)
About Rishiratna Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Bhikne, Nandkishor Bhikane, and Dheeraj Nagore serve as directors at the Company.
- CIN/LLPIN
U24233PN2015PTC153757
- Company No.
153757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2015
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rishiratna Remedies Private Limited offer?
Rishiratna Remedies Private Limited offers a wide range of products and services, including Facial Mask, Peel Off Mask, Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Cosmetics, Skin Care Cosmetics, Charcoal Peel off Mask.
Who are the key members and board of directors at Rishiratna Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkishor Bhikane  | Director | 16-Feb-2019 | Current |
| Anita Bhikne | Director | 16-Jan-2015 | Current |
| Dheeraj Nagore | Director | 24-Feb-2024 | Current |
Financial Performance of Rishiratna Remedies.
Rishiratna Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 89.07% decrease. The company also saw a substantial fall in profitability, with a 105.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rishiratna Remedies?
In 2021, Rishiratna Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rishiratna Remedies?
Unlock and access historical data on people associated with Rishiratna Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rishiratna Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishiratna Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
